Posters & Publications

Years of Research at Your Fingertips

ProMIS Neurosciences’ publications and posters provide ample background on our research surrounding neurodegenerative diseases.

Filter By:

EpiSelect™ Platform

Protein misfolding-specific epitope identification for passive and active immunotherapy of neurodegenerative diseases

View
PMN310 | Amyloid-Beta

PRECISE-AD, A Phase 1b, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PMN310 in Patients with Early Alzheimer's Disease

View
PMN310 | Amyloid-Beta

Leveraging recent advances in biomarkers to optimize early phase drug development in Alzheimer’s Disease

View
EpiSelect™ Platform

Prediction of Misfolding-Specific Epitopes in SOD1 Using EpiSelect™ (platform formerly called Collective Coordinates)

View
PMN267 | TDP-43

Rational Generation of Monoclonal Antibodies and Intrabodies Selective for Pathogenic TDP-43

View
PMN311 | AD Vaccine

Alzheimer's Disease Vaccine Presentation

View
PMN311 | AD Vaccine

Narration of Alzheimer's Disease Vaccine Presentation

View
PMN440 | A-Syn Vaccine

Alpha-synuclein Vaccine Presentation

View
PMN440 | A-Syn Vaccine

Narration of Alpha-synuclein Vaccine Presentation

View
PMN310 | Amyloid-Beta

Phase 1a Single Ascending Dose Study of PMN310, a monoclonal antibody directed against toxic Aβ oligomers

View
PMN310 | Amyloid-Beta

Distinguishing between Ab-directed antibodies: Ability of PMN310 to target toxic oligomers despite competing species

View
PMN311 | AD Vaccine

Novel approach to optimization of Alzheimer’s vaccine configuration for maximal targeting of toxic amyloid-beta oligomers

View